| Net Cash Provided by (Used in) Operating Activities |
$322,225 |
USD |
45% |
Q1 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$263,873 |
USD |
-53% |
Q1 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
691,528,945 |
shares |
34% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$58,352 |
USD |
-134% |
Q1 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$17,351 |
USD |
|
Q1 2024 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$1,270,500 |
USD |
187% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,270,500 |
USD |
186% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
100,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
100,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$6,956,393 |
USD |
152% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
100,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$23,914 |
USD |
|
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |